Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Antoniou, G. Soufla, E. Tzortzaki, G. Sourvinos, I. Politis, I. Drositis, D. Spandidos, N. Siafakas (Heraklion, Greece). Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis. Eur Respir J 2007; 30: Suppl. 51, 3413

Member's Comments

No comment yet.

Related content which might interest you: Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001 Hypoxia inducible factor-1? in human emphysema lung tissue Source: Eur Respir J 2011; 37: 775-783 Year: 2011 Growth factor regulation of lung fibrosis lessons from other organs Source: Annual Congress 2006 - Scientific year in review Year: 2006 Morphometric study of hypoxia inducible factor-1α-vascular endothelial growth factor (HIF-1α-VEGF) axis in patients with idiopathic pulmonary fibrosis with the use of tissue microarrays Source: Eur Respir J 2006; 28: Suppl. 50, 338s Year: 2006 Role of vascular endotelial growth factor polymorphisms in interstitial lung disease Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Increased expression of epidermal growth factor-receptor in idiopathic interstitial pneumonias. A tissue microarray study Source: Eur Respir J 2007; 30: Suppl. 51, 573s Year: 2007 Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF Source: Eur Respir J 2001; 17: 1220-1227 Year: 2001 NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 358s Year: 2001 MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009 Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Source: Eur Respir J 2006; 27: 957-963 Year: 2006 Interdependence of endothelin-1 and transforming growth factor-β1 on Wnt3a expression in idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001